Wuppertal, Germany

Hanno Wild

USPTO Granted Patents = 25 

 

Average Co-Inventor Count = 8.1

ph-index = 11

Forward Citations = 418(Granted Patents)


Location History:

  • Orange, CT (US) (1996 - 2000)
  • Wuppertal, DE (1992 - 2015)

Company Filing History:


Years Active: 1992-2015

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents

Title: Hanno Wild: Innovator in Cardiovascular and Hematological Disease Treatment

Introduction

Hanno Wild, a prominent inventor based in Wuppertal, Germany, holds an impressive portfolio of 25 patents. His pioneering work primarily focuses on novel therapeutic agents targeting cardiovascular and hematological diseases. Wild’s contribution to the field of medicinal chemistry is noteworthy, emphasizing innovative approaches to disease management.

Latest Patents

Among Hanno Wild's latest innovations are two significant patents that illustrate his expertise in drug development. The first patent entails "Substituted dihydropyrazolones for treating cardiovascular and hematological diseases." This application describes new substituted dihydropyrazolone derivatives, detailing their preparation processes and therapeutic uses for treating renal complications and enhancing wound healing.

The second patent, titled "4-(pyridin-3-yl)-2(pyridin-2-yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and hematological diseases," showcases Wild's dedication to advancing treatment methods for serious health conditions. This application focuses on dipyridyl-dihydropyrazolones and their potential for developing new medicaments that also address kidney and wound healing issues.

Career Highlights

Hanno Wild has had a distinguished career, primarily with Bayer Aktiengesellschaft and Bayer Intellectual Property GmbH. His tenure at these prestigious companies provided him with the platform to refine his research and innovation skills, contributing significantly to the field of pharmacology. His extensive work in pharmaceutical research underscores the importance of innovation in medical therapies.

Collaborations

Through his career, Wild has collaborated with notable professionals, including Jens-Kerim Ergüden and Rainer Endermann. Their collective expertise has facilitated the advancement of several groundbreaking patents, enhancing the therapeutic landscape for cardiovascular and hematological conditions.

Conclusion

Hanno Wild's innovations in the pharmaceutical domain showcase the vital role of dedicated inventors in developing new medical treatments. With a strong emphasis on novel compounds for serious diseases, Wild's contributions are set to improve patient outcomes and advance medical science. His work continues to inspire future innovations aimed at combating cardiovascular and hematological health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…